Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Propagermanium
Drug ID BADD_D01858
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D01626
MeSH ID C066750
PubChem ID 83030
TTD Drug ID Not Available
NDC Product Code Not Available
UNII 1Q2P9TO9Q7
Synonyms propagermanium | bis(carboxyethyl)germanium sesquioxide | DCEFSQD | carboxyethylgermanium sesquioxide | dicarboxyethenylgermanium sesquioxide | repagermanium | proxigermanium | dihydrogen bis(2-carboxylatoethyl)trioxodigermanate(2-) | bis(2-carboxyethyl)germanium sesquioxide | beta carboxyethylgermanium sesquioxide | 3,3'-(1,3-dioxo-1,3-digermoxanediyl)dipropionic acid | Ge 132 | Germanium-132 | Ge-132 | Arlamol Gel | 3-oxygermylpropionic acid polymer | SK 818 | SK-818
Chemical Information
Molecular Formula C6H10Ge2O7
CAS Registry Number 12758-40-6
SMILES C(C[Ge](=O)O[Ge](=O)CCC(=O)O)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Vision blurred17.17.01.010; 06.02.06.007--
VIth nerve paralysis17.04.02.002; 06.05.02.009--Not Available
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Tubulointerstitial nephritis20.05.02.002--Not Available
Musculoskeletal disorder15.03.05.025--Not Available
Brain oedema17.07.02.003; 12.01.10.010--
Quadriparesis17.01.04.012--Not Available
Left ventricular dysfunction02.04.02.011--
Acute coronary syndrome24.04.04.011; 02.02.02.015--Not Available
Cytokine release syndrome10.02.01.010--
Haemodynamic instability24.03.02.006--Not Available
Musculoskeletal stiffness15.03.05.027--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Vascular occlusion24.04.02.015--Not Available
Affect lability19.04.01.001--Not Available
Cognitive disorder19.21.02.001; 17.03.03.003--
Nuchal rigidity17.05.02.006; 15.05.04.005--Not Available
Vasodilation procedure25.03.01.001--Not Available
Muscle relaxant therapy25.16.01.001--Not Available
Bacterial infection11.02.01.005--Not Available
Central nervous system infection17.06.09.001; 11.01.03.004--Not Available
Lymphoproliferative disorder16.21.02.001; 01.13.02.001--Not Available
Malnutrition14.03.02.004--Not Available
Mental disorder19.07.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Ill-defined disorder08.01.03.049--Not Available
Autonomic neuropathy17.05.01.009--Not Available
Obstructive airways disorder22.03.01.011--Not Available
Psychotic disorder19.03.01.002--
The 6th Page    First    Pre   6 7    Next   Last    Total 7 Pages